Recent Quarter Total Invested
$1,874
Recent Quarter Institutional Ownership Percentage
5.17%
Total Invested of Last Quarter
$6,757
Ownership Percentage of Last Quarter
4.66%
Protagenic Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WARBERG ASSET MANAGEMENT LLC | 08/09/2024 | 177,196 | $1,453 | 0.00% | 4.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 26,600 | $218 | 100.00% | 0.60% |
| GTS SECURITIES LLC | 08/14/2024 | 25,300 | $202 | -0.39% | 0.57% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 100 | $1 | 100.00% | 0.00% |
Protagenic Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PTIXW shares?
During the previous two years, 3 institutional investors and hedge funds held shares of Protagenic Therapeutics, Inc.. The most heavily invested institutionals were:
Warberg Asset Management LLC: 177,196
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 46,615
BANK OF AMERICA CORP /DE/: 0
-
What percentage of Protagenic Therapeutics, Inc. stock is owned by institutional investors?
5.17% of Protagenic Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at PTIXW ?
Institutional investors have bought a total of 223,811 shares in the last 24 months. This purchase volume represents approximately $2,238 in transactions.